Big Brain
Posts
🧠 AI-generated fake news story goes viral

🧠 AI-generated fake news story goes viral

PLUS: AI takes CRISPR to the next level

Alan Buxbaum & Alex Valaitis
July 04, 2023

📢 Sponsor | 💼 AI Jobs | 🐦 Twitter | 📰 Past Editions

Hey Big Brain fam,

While many of our readers are on holiday, we have a global audience. So we still have a new edition for you all today.

Happy 4th of July to those celebrating in America! 🇺🇸

Today's AI spotlights:

AI-generated fake news story goes viral 👎
AI takes CRISPR to the next level 🧬

📢 FEATURED AI PRODUCT: Bitskout

Meet Bitskout, a super cool AI tool to make your life easier!

With just a few clicks, it helps you get important info from your papers and documents quickly. You don't need to be an expert - anyone can use it! Give Bitskout a try and see how it can make boring tasks fun and simple!

👎 AI-GENERATED FAKE NEWS STORY GOES VIRAL

Fake news spread about SEC Chairman Gary Gensler's alleged resignation, after an internal investigation determined it was generated by an AI tool.

This highlights a grave issue: AI tools can't always verify source reliability, leading to the propagation of false news.

The original source, an AI text generator, was not identified, and it’s possible that the training content was initially seeded by a satirical author.

While a trained eye can distinguish between fabricated and confirmed news, AI-propagated fake news is a growing problem, especially as many lack the ability to verify news reliability.

The lesson? Always rely on sources you trust, and question everything else

📰 Full Article Here

🧬 AI TAKES CRISPR TO THE NEXT LEVEL

Anyone out there remember CRISPR? Imagine legos, except you're playing with DNA.

Well, NYU and Columbia University researchers have cooked up a new AI called TIGER. It predicts the activity of RNA-targeting CRISPR tools, like flicking a light switch for genes.

Think precise gene control and therapy development. It's a leap forward in biomedicine, and could help treat everything from sickle cell to the flu.

But here's the kicker: TIGER aims for 'on-target' activity and avoids 'off-target' side effects. That means more accuracy and fewer potential issues.

With this, gene dosage modulation and avoidance of off-target CRISPR activity seem within reach.

📰 Full Article Here